If you did not receive your new sign-in credentials via email or have any problems, please email Customer System Support at CustomerSystemsSupport@amerisourcebergen.com - include your current user ID, name and email with your inquiry.
What are biosimilars?
Differences between generics and biosimilars
What to know about biosimilars
As a clinician, you can help drive long-term stability in the biosimilars market. As your strategic GPO partner, we provide your practice with easier access to biosimilars entering the market so you can make the best choice for your patients' care.
Biosimilars are often cheaper for specialty physician practices than their reference products. Both Medicare and private insurers support the use of biosimilars and reimburse at a competitive rate. Plus, upcoming legislation has the potential to positively impact reimbursement. That’s a win-win. You can be confident that your practice’s finances will sustain or improve when your clinicians choose biosimilar products.
As trusted advisors, specialty physicians should recommend biosimilar use. Think about adding a “substitute biosimilars” option to your patient consent forms to incorporate them into care plans. Start a conversation with patients to answer their questions and build their trust.
Create sustained value with biosimilars
Build your biosimilar strategy
Insights from our experts
Five Years on, Biosimilars Need Support from All Health Care Players